Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A randomized trial Academic Article uri icon

Overview

MeSH Major

  • Antiviral Agents
  • Cytomegalovirus Infections
  • Ganciclovir
  • Hematopoietic Stem Cell Transplantation

abstract

  • Roche Laboratories.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4465336

Digital Object Identifier (DOI)

  • 10.7326/M13-2729

PubMed ID

  • 25560711

Additional Document Info

start page

  • 1

end page

  • 10

volume

  • 162

number

  • 1